Author:
Takada Eiko,Hata Kikumi,Mizuguchi Junichiro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference42 articles.
1. Zamboglou N, Schnabel T, Kolotas C, Achterrath W, Strehl H, Dalhauser S, Vogt HG, Lenaz L, Schmitt G (1994) Carboplatin and radiotherapy in the treatment of head and neck cancer: six years’ experience. Semin Oncol 21:45–53
2. Niitani H, Kobayashi K (1992) Cisplatin/carboplatin therapy in non-small cell lung cancer. Oncology 49(Suppl 1):51–56
3. Mey UJ, Olivieri A, Orlopp KS, Rabe C, Strehl JW, Gorschlueter M, Hensel M, Flieger D, Glasmacher AG, Schmidt-Wolf IG (2006) DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis. Leuk Lymphoma 47:2558–2566
4. Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33:9–23
5. Wernyj RP, Morin PJ (2004) Molecular mechanisms of platinum resistance: still searching for the Achilles’ heel. Drug Resist Updat 7:227–232
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献